跳至主要内容
临床试验/NCT01815788
NCT01815788已完成不适用

Evaluation of Efficacy and Patient Acceptance of Sound Amplifier Téo First, in Mild and Moderate Presbycusis Patient 60 Years of Age and Older, With no Previous Hearing Aid.

Centre Hospitalier Universitaire de Nice2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2013年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
2
主要终点
Audiometric tests (pure tone and speech) in silence and noise, with and without Teofirst

研究概览

简要总结

A personal sound amplifying device (PASP) like Teo First is a wearable electronic product that is not intended to compensate for impaired hearing, but rather is intended for non-hearing impaired consumers to amplify sounds in the environment for a number of reasons, such as for recreational activities. Nevertheless, a lot of mild and moderate impaired hearing people don't want to buy and wear all day a real hearing aid.

The goal of our study is to evaluate the benefit of such a device for mild and moderate presbycusis patient 60 years of age and older, with no previous hearing aid.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
60 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Wish to increase hearing
  • Moral commitment to use the device
  • Ability to understand the study
  • Mild and moderate presbycusis (20 to 50 dB average hearing loss at 500, 1000, 2000 Hz and 4000 Hz)
  • Patient 60 years of age and older,
  • No previous hearing aid

排除标准

  • Inability to use the device
  • Previous use of a hearing aid
  • local intolerance

结局指标

主要结局

Audiometric tests (pure tone and speech) in silence and noise, with and without Teofirst

时间窗: 7 to 15 days after the first use of Teofirst

次要结局

  • audiometric and mental tests(D7 to 15 and D 40)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验